The Centre for the Right to Health has called for investment in new HIV prevention and treatment, Pre- exposure Prophylaxis, (PReP) as it helps in reducing infection.
Speaking to journalists in Lagos during a two-day media training on biomedical HIV prevention in Nigeria, the program director of the centre, Mr Bede Eziefule, said PReP is a drug that HIV negative persons can take to prevent being positive especially those that are sexually active, adding that it has been proven to be 90 percent effective when used correctly and consistently. Read More
